Publications

Found 45 results
Filters: Keyword is Biomarkers  [Clear All Filters]
2019
Kim Y-R, Baek J-I, Kim SHwan, Kim M-A, Lee B, Ryu N, Kim K-H, Choi D-G, Kim H-M, Murphy MP, Macpherson G, Choo Y-S, Bok J, Lee K-Y, Park J-W & Kim U-K (2019) Therapeutic potential of the mitochondria-targeted antioxidant MitoQ in mitochondrial-ROS induced sensorineural hearing loss caused by Idh2 deficiency. Redox Biol 20, 544-555
2017
Jalloh I, Helmy A, Howe DJ, Shannon RJ, Grice P, Mason A, Gallagher CN, Stovell MG, van der Heide S, Murphy MP, Pickard JD, Menon DK, T Carpenter A, Hutchinson PJ & Carpenter KLh (2017) Focally perfused succinate potentiates brain metabolism in head injury patients. J Cereb Blood Flow Metab 37, 2626-2638
Steele HE, Horvath R, Lyon JJ & Chinnery PF (2017) Monitoring clinical progression with mitochondrial disease biomarkers. Brain 140, 2530-2540
2016
Lehtonen JM, Forsström S, Bottani E, Viscomi C, Baris OR, Isoniemi H, Höckerstedt K, Österlund P, Hurme M, Jylhävä J, Leppä S, Markkula R, Heliö T, Mombelli G, Uusimaa J, Laaksonen R, Laaksovirta H, Auranen M, Zeviani M, Smeitink J, Wiesner RJ, Nakada K, Isohanni P & Suomalainen A (2016) FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders. Neurology 87, 2290-2299
2014
Carpenter KLH, Jalloh I, Gallagher CN, Grice P, Howe DJ, Mason A, Timofeev I, Helmy A, Murphy MP, Menon DK, Kirkpatrick PJ, T Carpenter A, Sutherland GR, Pickard JD & Hutchinson PJ (2014) (13)C-labelled microdialysis studies of cerebral metabolism in TBI patients. Eur J Pharm Sci 57, 87-97
Logan A, Cochemé HM, Pun PBoon Li, Apostolova N, Smith RAJ, Larsen L, Larsen DS, James AM, Fearnley IM, Rogatti S, Prime TA, Finichiu PG, Dare A, Chouchani ET, Pell VR, Methner C, Quin C, McQuaker SJ, Krieg T, Hartley RC & Murphy MP (2014) Using exomarkers to assess mitochondrial reactive species in vivo. Biochim Biophys Acta 1840, 923-30
2010
Joosen AMCP, Lecommandeur E, Kuhnle GGC, Aspinall SM, Kap L & Rodwell SA (2010) Effect of dietary meat and fish on endogenous nitrosation, inflammation and genotoxicity of faecal water. Mutagenesis 25, 243-7
Gane EJ, Weilert F, Orr DW, Keogh GF, Gibson M, Lockhart MM, Frampton CM, Taylor KM, Smith RAJ & Murphy MP (2010) The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int 30, 1019-26
2008
Bingham S, Luben R, Welch A, Low YLing, Khaw KTee, Wareham N & Day N (2008) Associations between dietary methods and biomarkers, and between fruits and vegetables and risk of ischaemic heart disease, in the EPIC Norfolk Cohort Study. Int J Epidemiol 37, 978-87
Norat T, Bowman R, Luben R, Welch A, Khaw KTee, Wareham N & Bingham S (2008) Blood pressure and interactions between the angiotensin polymorphism AGT M235T and sodium intake: a cross-sectional population study. Am J Clin Nutr 88, 392-7
Peluso M, Airoldi L, Munnia A, Colombi A, Veglia F, Autrup H, Dunning A, Garte S, Gormally E, Malaveille C, Matullo G, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Palli D, Krogh V, Tumino R, Panico S, Bueno-de-Mesquita BH, Peeters PH, Kumle M, Agudo A, Martinez C, Dorronsoro M, Barricarte A, Tormo MJosé, Quirós JRamón, Berglund G, Jarvholm B, Day NE, Key TJ, Saracci R, Kaaks R, Riboli E, Bingham S & Vineis P (2008) Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective study. Br J Nutr 100, 489-95
Kuhnle GGC, Joosen AMCP, Wood TR, Runswick SA, Griffin JL & Bingham SA (2008) Detection and quantification of sucrose as dietary biomarker using gas chromatography and liquid chromatography with mass spectrometry. Rapid Commun Mass Spectrom 22, 279-82
Capellá G, Pera G, Sala N, Agudo A, Rico F, Del Giudicce G, Plebani M, Palli D, Boeing H, H Bueno-de-Mesquita B, Carneiro F, Berrino F, Vineis P, Tumino R, Panico S, Berglund G, Simán H, Nyrén O, Hallmans G, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quirós JR, Allen N, Key T, Bingham S, Caldas C, Linseisen J, Nagel G, Overvad K, Tjonneland A, Boshuizen HC, Peeters PHM, Numans ME, Clavel-Chapelon F, Trichopoulou A, Lund, iv E, Jenab M, Kaaks R, Riboli E & González CA (2008) DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int J Epidemiol 37, 1316-25
Tasevska N, Runswick SA, McTaggart A & Bingham SA (2008) Twenty-four-hour urinary thiamine as a biomarker for the assessment of thiamine intake. Eur J Clin Nutr 62, 1139-47
Joosen AMCP, Kuhnle GGC, Runswick SA & Bingham SA (2008) Urinary sucrose and fructose as biomarkers of sugar consumption: comparison of normal weight and obese volunteers. Int J Obes (Lond) 32, 1736-40
Neuhouser ML, Tinker L, Shaw PA, Schoeller D, Bingham SA, Van Horn L, Beresford SAA, Caan B, Thomson C, Satterfield S, Kuller L, Heiss G, Smit E, Sarto G, Ockene J, Stefanick ML, Assaf A, Runswick S & Prentice RL (2008) Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. Am J Epidemiol 167, 1247-59
2007
Greetham HL, Bingham SA & Burns PA (2007) Adduction of human p53 gene by fecal water: an in vitro biomarker of mutagenesis in the human large bowel. Cancer Epidemiol Biomarkers Prev 16, 2681-5
Bingham S, Luben R, Welch A, Tasevska N, Wareham N & Khaw KTee (2007) Epidemiologic assessment of sugars consumption using biomarkers: comparisons of obese and nonobese individuals in the European prospective investigation of cancer Norfolk. Cancer Epidemiol Biomarkers Prev 16, 1651-4
2006
Low Y-L, Taylor JI, Grace PB, Mulligan AA, Welch AA, Scollen S, Dunning AM, Luben RN, Khaw K-T, Day NE, Wareham NJ & Bingham SA (2006) Phytoestrogen exposure, polymorphisms in COMT, CYP19, ESR1, and SHBG genes, and their associations with prostate cancer risk. Nutr Cancer 56, 31-9
Canoy D, Wareham N, Luben R, Welch A, Bingham S, Day N & Khaw K-T (2006) Serum lipid concentration in relation to anthropometric indices of central and peripheral fat distribution in 20,021 British men and women: results from the EPIC-Norfolk population-based cohort study. Atherosclerosis 189, 420-7
Rip J, Nierman MC, Wareham NJ, Luben R, Bingham SA, Day NE, van Miert JNI, Hutten BA, Kastelein JJP, Kuivenhoven JAlbert, Khaw K-T & S Boekholdt M (2006) Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 26, 637-42
Tasevska N, Runswick SA & Bingham SA (2006) Urinary potassium is as reliable as urinary nitrogen for use as a recovery biomarker in dietary studies of free living individuals. J Nutr 136, 1334-40

Pages